CAC Software vs Rapid Aortic Measurements

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Imbio
VS
by iSchemaView

AI Verdict

Imbio's CAC Software is specialized for quantifying coronary artery calcification from non-contrast chest CTs to assess coronary artery disease risk. In contrast, Rapid Aortic Measurements by iSchemaView focuses on automated measurement and 3D reconstruction of aortic structures for the acute assessment and longitudinal management of aortic disease. While both are cardiology AI tools utilizing CT imaging, their distinct anatomical targets and clinical applications mean they address different diagnostic needs within cardiology.

Choose CAC Software if…

Choose CAC Software if your primary objective is to assess a patient's risk for coronary artery disease by quantifying coronary artery calcification. This tool is ideal for radiologists and cardiologists seeking automated, deep-learning based analysis from non-contrast chest CT scans to generate Agatston scores, arterial age, and other key metrics for cardiovascular risk stratification.

View CAC Software →

Choose Rapid Aortic Measurements if…

Choose Rapid Aortic Measurements if you require comprehensive, automated analysis and longitudinal management of aortic disease. This software is best suited for clinicians needing rapid, accurate measurements and 3D reconstructions of the entire aorta from various CT scan types, including post-treatment studies, to facilitate acute assessment and track anatomical changes over time.

View Rapid Aortic Measurements →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CAC Software Rapid Aortic Measurements
Pricing Contact for pricing Contact for pricing
Deployment Cloud, On-premise, Partner platforms Cloud, On-premise, Hybrid
BAA Available Unknown Yes AI-estimated
FDA Status 1 AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rapid Aortic Measurements

Tool A emphasizes a fully automated, no-user-interface approach, integrating directly into DICOM workflows and PACS for 'first-read ready' results. Tool B, as part of the Rapid Enterprise Platform, offers broader integration with PACS, RIS, EMR, and mobile/web applications, including features like worklist prioritization and structured reporting, suggesting a more comprehensive and unified user experience within a larger ecosystem.

Clinical Value

Rapid Aortic Measurements

Both tools offer significant clinical value in their respective specialties. Tool A provides detailed coronary artery calcification quantification, including Agatston score and arterial age, from non-contrast CTs for CAD risk assessment. Tool B, however, offers comprehensive, guideline-based aortic measurements, automated 3D reconstructions, and crucial longitudinal tracking for acute assessment and ongoing management of aortic disease, backed by claims of being the 'most clinically validated AI platform in healthcare' with over 700 clinical studies.

Pricing & Value

Tie

Both Tool A and Tool B state 'Contact for pricing' in their specifications, and no public pricing information or detailed cost-benefit analyses were found through web searches. Without transparent pricing or comparative value propositions, it is not possible to determine a winner in this dimension.

Enterprise Readiness

Rapid Aortic Measurements

Both tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, BAA, and flexible deployment options (cloud, on-premise, partner platforms/hybrid). However, Tool B highlights 'unlimited scalability,' deployment in 'hundreds of health systems nationwide,' and comprehensive integration with EHRs, RIS, and third-party platforms within its Rapid Enterprise Platform, indicating a more mature and widely adopted enterprise-scale solution.

Innovation

Rapid Aortic Measurements

Both leverage AI for automated medical image analysis. Tool A innovates by providing arterial age and calcified lesion mass/volume from non-contrast CTs. Tool B, with its 'deep clinical AI' approach, offers 24 guideline-based measurements, automated 3D reconstructions, and robust longitudinal tracking for patient surveillance and management, extending beyond initial detection to 'full patient management,' which represents a broader and more advanced application of AI in ongoing care.

Support & Docs

Rapid Aortic Measurements

Tool A offers 24/7/365 email and website support, with phone support during business hours, and provides user manuals upon request. Tool B provides 24/7/365 global customer support via email and phone, with multiple international numbers and language fluency, alongside a more extensive array of publicly available resources including a Help Center, Documentation, API Reference, Case Studies, and educational materials.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CAC Software Rapid Aortic Measurements
Name CAC Software Rapid Aortic Measurements
Company Imbio iSchemaView
Description Focus Automated image post-processing for coronary artery calcification from non-contrast chest CT Automated, accurate measurement and 3D reconstruction of aortic structures from CT scans
Key Output Metrics Agatston score, arterial age, calcified lesion mass and volume, 3D visualizations and annotated images 24 automated guideline-based aortic measurements (6 zonal maximums, 18 landmark metrics), automated 3D image reconstructions, 2D and 3D visualizations
Specialties Cardiology, Radiology Cardiology, Radiology, Vascular Surgery

Videos

Demos, reviews, and walkthroughs featuring CAC Software and Rapid Aortic Measurements.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio's CAC Software is designed to help determine the location and calculate the amount of calcification within the coronary arteries, supporting risk assessment for coronary artery disease. Rapid Aortic Measurements by iSchemaView aids in the acute assessment and longitudinal management of aortic disease by analyzing aortic structures.
Imbio's Coronary Artery Calcification (CAC) software analyzes non-contrast chest computed tomography (CT) scans. Rapid Aortic Measurements can process all CT scans that include the aorta, including post-treatment and non-contrast studies.
Imbio's CAC software outputs the Agatston score, arterial age, calcified lesion mass, and volume. Rapid Aortic Measurements provides 24 automated guideline-based aortic measurements, which include 6 zonal maximums and 18 landmark metrics.
Rapid Aortic Measurements explicitly offers longitudinal tracking and comparison of anatomical changes in aortic structures over time for patient surveillance. Imbio's CAC software focuses on risk assessment for coronary artery disease, but longitudinal tracking of CAC changes is not explicitly detailed as a feature in the same way.
Imbio's CAC software integrates into existing DICOM viewing workflows. Rapid Aortic Measurements is integrated into the Rapid Enterpriseu2122 Platform and can also be accessed via Rapid mobile and web applications.
Imbio's CAC software provides 3D visualizations and annotated images of coronary artery calcification. Rapid Aortic Measurements offers automated 3D image reconstructions of the entire aorta, along with 2D and 3D visualizations of segmented vessels.
AI Tool Finder
AI-powered search. Results may not be comprehensive.